Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
checkpoint inhibitors
Pharma
FDA limits Keytruda, Opdivo uses in stomach cancer
The two PD-1 inhibitors' FDA labels in gastric, gastroesophageal junction and esophageal cancers have been reduced to PD-L1-positive tumors only.
Angus Liu
Jun 9, 2025 10:50am
ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop
Jun 3, 2025 8:00am
Sun Pharma buys Checkpoint Therapeutics for up to $416M
Mar 10, 2025 10:23am
Leo bags Loqtorzi rights, putting marketing muscle behind launch
Jan 21, 2025 11:15am
GSK trial result mirrors Merck's problem in ovarian cancer
Dec 20, 2024 10:46am
ESMO: BMS moves Opdualag into phase 3 trials in 1L NSCLC
Sep 14, 2024 2:40am
